LEO 39652 is a novel PDE4 ингибитор с IC50 of 3.8 nM and selected as a clinical candidate as it is мощный and rapidly degraded by blood and liver to inactive metabolites.
Оригинал на английском
LEO 39652 is a novel PDE4 inhibitor with IC50 of 3.8 nM and selected as a clinical candidate as it is potent and rapidly degraded by blood and liver to inactive metabolites.